Page last updated: 2024-11-05

trimetrexate and Cancer of Skin

trimetrexate has been researched along with Cancer of Skin in 1 studies

Trimetrexate: A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting toxic effect.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harris, PJ1

Other Studies

1 other study available for trimetrexate and Cancer of Skin

ArticleYear
Trimetrexate glucuronate associated with anti-Kaposi sarcoma effect.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:5

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Agents; Drug Combinations; Glucuronates

1996